![](/img/cover-not-exists.png)
1977 Synergy of LCL161, an antagonist of inhibitor of apoptosis proteins (IAPs), with paclitaxel in a gene expression signature-enriched cohort of triple-negative breast cancer (TNBC)
Bardia, A., Cameron, J.S., Venkatesan, K., Robinson, D., Porter, D., Kim, S.B., Parton, M., Kümmel, S., Estevez, L.G., Huang, C.S., Cortes Castan, J., Ruiz-Borrego, M., Telli, M., Martín Martorell, P.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)30925-x
Date:
September, 2015
File:
PDF, 63 KB
english, 2015